Delfi_CASCADE Study (Lung Cancer Screening) - Clinical Trial

What is the Purpose of this Study?

Treatment

We are doing this study to find out if an experimental blood test can help us detect lung cancer better.

What is the Condition Being Studied?
Objective

Lung Cancer Screening

Who Can Participate in the Study?

Key Eligibility

Adults ages 50+ who:
- Are current or former smokers
- Have a smoking history equal to 20 "pack years" [pack years = the number of packs you smoke(d) per day multiplied by the number of years you have smoked]
- Have an initial or annual follow-up lung cancer screening chest CT planned or scheduled to be done at Duke

For more information about who can be in this study, please contact the study team at 919-668-5055.

Age Group
Adults

What is Involved?

Description

If you choose to join the study, you will:
- Have a blood draw
- Complete your routine or standard of care chest CT scan for lung cancer screening
- Participate in a 4 & 12 month medical record review, if applicable
- Give us permission to collect your health information for up to 5 years after you join the study

Study Details

Full Title
Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung
Principal Investigator
Tobacco Cessation Specialist
Protocol Number
IRB: PRO00110588
NCT: NCT05306288
Phase
Phase I
ClinicalTrials.gov
Enrollment Status
Open for Enrollment